drugset / Trial / NCT00509678

Rituxan With or Without Methotrexate in Psoriatic Arthritis

NCT00509678 ↗

Phase 1 Completed 6 enrolled Swedish Medical Center Genentech, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to help determine the effectiveness of rituxan (with or without methotrexate) in the treatment of psoriatic arthritis.

Timeline

Start
2006-12
Primary completion
2010-01
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Rituximab Monoclonal antibody 1000 mg Intravenous

Indications